Kyntra Bio, Inc. (KYNB) Ownership
KYNB ownership summary
as of October 18, 2026- Institutions
- 24.7% of shares outstanding
- Insiders
- 2.02% of shares outstanding
- Shares outstanding
- 4.0M
- Float
- 3.6M shares available to trade
- Short interest
- 2.52% 100K shares short
- Days to cover
- 3.87 short interest down 0.7% vs prior month
- Institutions 24.68%
- Insiders 2.02%
- Other investors 73.31%
KYNB top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 9.88% | 400K | $1.9M | — | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 3.95% | 160K | $775,758 | +3,343 (+2.1%) | June 30, 2026 |
| 3 | Acadian Asset Management LLC | 2.61% | 106K | $512,087 | — | June 30, 2026 |
| 4 | BlackRock Inc | 2.08% | 84K | $409,000 | −1 (−0.0%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 1.07% | 43K | $209,612 | −2,779 (−6.0%) | June 30, 2026 |
| 6 | HighTower Advisors, LLC | 0.98% | 40K | $192,768 | +2 (+0.0%) | June 30, 2026 |
| 7 | Two Sigma Investments LLC | 0.98% | 40K | $191,628 | −10,000 (−20.2%) | June 30, 2026 |
| 8 | Renaissance Technologies Corp | 0.67% | 27K | $131,343 | −400 (−1.5%) | June 30, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 0.60% | 24K | $116,909 | +163 (+0.7%) | June 30, 2026 |
| 10 | Birchview Capital, LP | 0.56% | 23K | $109,445 | — | June 30, 2026 |
| 11 | State Street Corp | 0.50% | 20K | $98,377 | — | June 30, 2026 |
| 12 | GSA Capital Partners LLP | 0.39% | 16K | $76,130 | +15,697 (0.0%) | June 30, 2026 |
| 13 | UBS Group AG | 0.19% | 7,857 | $38,106 | −19,734 (−71.5%) | June 30, 2026 |
| 14 | Group One Trading, LLC | 0.11% | 4,406 | $21,369 | −86 (−1.9%) | June 30, 2026 |
| 15 | Vanguard Global Advisers, LLC | 0.04% | 1,424 | $6,906 | — | June 30, 2026 |
| 16 | Tower Research Capital LLC | 0.03% | 1,113 | $5,398 | +781 (+235.2%) | June 30, 2026 |
| 17 | Axiom Investment Management LLC | 0.02% | 704 | $3,414 | — | June 30, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 0.01% | 487 | $2,362 | −1 (−0.2%) | June 30, 2026 |
| 19 | HARBOUR INVESTMENTS, INC. | <0.01% | 200 | $970 | — | June 30, 2026 |
| 20 | NATIONAL BANK OF CANADA /FI/ | <0.01% | 193 | $936 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 5 holders added 20K shares and 7 cut 33K.
KYNB top mutual fund and ETF holders
10 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.82% | 114K | $553,768 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.47% | 19K | $91,762 | −102 (−0.5%) | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.17% | 7,005 | $33,974 | — | August 31, 2026 |
| 4 | Fidelity Series Total Market Index | 0.14% | 5,744 | $27,858 | — | August 31, 2026 |
| 5 | Vanguard Balanced Index Inv | 0.09% | 3,506 | $17,004 | — | August 31, 2026 |
| 6 | Vanguard Capital Opportunity Inv | 0.07% | 2,716 | $13,173 | — | June 30, 2026 |
| 7 | Fidelity Nasdaq Composite Index | 0.05% | 1,991 | $9,656 | — | August 31, 2026 |
| 8 | Vanguard U.S. Eq Idx £ Acc | 0.04% | 1,424 | $6,906 | — | August 31, 2026 |
| 9 | BSF Systematic US Eq Abs Ret A2 USD | <0.01% | 23 | $112 | — | December 31, 2025 |
| 10 | Knights of Columbus U.S. All Cap Idx I | <0.01% | 22 | $107 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
KYNB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns KYNB
Institutional investors own 24.7% of Kyntra Bio's shares and insiders 2.02%. The largest holder is Armistice Capital, LLC with 9.88% of the shares (400K), as of June 30, 2026. Among the top 20 institutions, 5 added shares and 7 reduced their stake in the latest filings. Short interest is 2.52% of the float, or 3.87 days of average trading volume. The share count rose 81.6% since 2014.
Related: KYNB analyst forecast, KYNB key metrics. See the KYNB stock overview for the latest quote and news.
KYNB ownership FAQ
Who owns the most Kyntra Bio stock?
The largest shareholders of Kyntra Bio are Armistice Capital, LLC (9.88%), Vanguard Capital Management, LLC (3.95%), Acadian Asset Management LLC (2.61%), BlackRock Inc (2.08%), Geode Capital Management, LLC (1.07%).
What percentage of Kyntra Bio is owned by institutions?
Institutions hold 24.7% of Kyntra Bio's shares outstanding; insiders hold 2.02%.
Which funds own Kyntra Bio?
The largest fund holders of Kyntra Bio are Vanguard MStar Total Stk Mkt Idx Invest (2.82%), Fidelity Extended Market Index (0.47%), Fidelity Total Market Index (0.17%), Fidelity Series Total Market Index (0.14%), Vanguard Balanced Index Inv (0.09%).
What is Kyntra Bio's short interest?
100K shares of Kyntra Bio were sold short, 2.52% of the float; at the average daily volume it would take 3.87 days to cover.
How many shares of Kyntra Bio are outstanding?
Kyntra Bio has 4.0M shares outstanding, of which 3.6M are in the public float.